Acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are well recognized complications of transfusion but it has been unclear which particular blood products put patients at risk. This retrospective cohort study in Chest confirmed that ARDS and ALI follow blood product transfusion and identified the highest risk for platelet and plasma transfusions.
Background: FDA advisory on transfusion related acute lung injury (TRALI).
No comments:
Post a Comment